{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T20:52:07Z","timestamp":1765486327082},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T00:00:00Z","timestamp":1563494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T00:00:00Z","timestamp":1563494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Derm Rep"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s13671-019-00265-2","type":"journal-article","created":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T10:02:37Z","timestamp":1563530557000},"page":"122-132","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Updates on Treatment Approaches for Cutaneous Field Cancerization"],"prefix":"10.1007","volume":"8","author":[{"given":"Alisen","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie K.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evan","family":"Austin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Mamalis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jared","family":"Jagdeo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,19]]},"reference":[{"issue":"6","key":"265_CR1","first-page":"415","volume":"97","author":"J Lanoue","year":"2016","unstructured":"\u2022\u2022 Lanoue J, Chen C, Goldenberg G. Actinic keratosis as a marker of field cancerization in excision specimens of cutaneous malignancies. Cutis. 2016;97(6):415\u201320. Provides evidence that field cancerization is present in basal cell carcinoma and malignant melanoma.","journal-title":"Cutis"},{"key":"265_CR2","doi-asserted-by":"publisher","unstructured":"Christensen SR. Recent advances in field cancerization and management of multiple cutaneous squamous cell carcinomas. F1000Research. 2018;7. \n                                 https:\/\/doi.org\/10.12688\/f1000research.12837.1\n                                 \n                              .","DOI":"10.12688\/f1000research.12837.1"},{"issue":"5","key":"265_CR3","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q","volume":"6","author":"DP Slaughter","year":"1953","unstructured":"Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer. 1953;6(5):963\u20138.","journal-title":"Cancer"},{"issue":"10","key":"265_CR4","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1001\/jamadermatol.2015.1187","volume":"151","author":"HW Rogers","year":"2015","unstructured":"Rogers HW, Weinstock MA, Feldman SR, Coldiron BM. Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the U.S. population, 2012. JAMA Dermatol. 2015;151(10):1081\u20136. \n                                 https:\/\/doi.org\/10.1001\/jamadermatol.2015.1187\n                                 \n                              .","journal-title":"JAMA Dermatol"},{"issue":"4","key":"265_CR5","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1111\/jdv.14652","volume":"32","author":"I Figueras Nart","year":"2018","unstructured":"Figueras Nart I, Cerio R, Dirschka T, Dreno B, Lear JT, Pellacani G, et al. Defining the actinic keratosis field: a literature review and discussion. J Eur Acad Dermatol Venereol. 2018;32(4):544\u201363. \n                                 https:\/\/doi.org\/10.1111\/jdv.14652\n                                 \n                              .","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"265_CR6","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.jaad.2016.12.043","volume":"76","author":"HW Lim","year":"2017","unstructured":"Lim HW, Collins SAB, Resneck JS Jr, Bolognia JL, Hodge JA, Rohrer TA, et al. The burden of skin disease in the United States. J Am Acad Dermatol. 2017;76(5):958\u201372.e2. \n                                 https:\/\/doi.org\/10.1016\/j.jaad.2016.12.043\n                                 \n                              .","journal-title":"J Am Acad Dermatol"},{"key":"265_CR7","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1001\/jamadermatol.2018.3086","volume":"154","author":"H Yeung","year":"2018","unstructured":"Yeung H, Baranowski ML, Swerlick RA, Chen SC, Hemingway J, Hughes DR, et al. Use and cost of actinic keratosis destruction in the Medicare Part B fee-for-service population, 2007 to 2015. JAMA Dermatol. 2018;154:1281\u20135. \n                                 https:\/\/doi.org\/10.1001\/jamadermatol.2018.3086\n                                 \n                              .","journal-title":"JAMA Dermatol"},{"key":"265_CR8","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1111\/bjd.17096","volume":"180","author":"E Wenande","year":"2018","unstructured":"Wenande E, Phothong W, Bay C, Karmisholt KE, Haedersdal M, Togsverd-Bo K. Efficacy and safety of daylight photodynamic therapy after tailored pretreatment with ablative fractional laser or microdermabrasion: a randomized, side-by-side, single-blind trial in patients with actinic keratosis and large-area field cancerization. Br J Dermatol. 2018;180:756\u201364. \n                                 https:\/\/doi.org\/10.1111\/bjd.17096\n                                 \n                              .","journal-title":"Br J Dermatol"},{"issue":"3","key":"265_CR9","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/bjd.12420","volume":"169","author":"RN Werner","year":"2013","unstructured":"Werner RN, Sammain A, Erdmann R, Hartmann V, Stockfleth E, Nast A. The natural history of actinic keratosis: a systematic review. Br J Dermatol. 2013;169(3):502\u201318. \n                                 https:\/\/doi.org\/10.1111\/bjd.12420\n                                 \n                              .","journal-title":"Br J Dermatol"},{"issue":"11","key":"265_CR10","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1002\/cncr.24284","volume":"115","author":"VD Criscione","year":"2009","unstructured":"Criscione VD, Weinstock MA, Naylor MF, Luque C, Eide MJ, Bingham SF. Actinic keratoses: natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial. Cancer. 2009;115(11):2523\u201330. \n                                 https:\/\/doi.org\/10.1002\/cncr.24284\n                                 \n                              .","journal-title":"Cancer"},{"issue":"7","key":"265_CR11","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1002\/hed.24765","volume":"39","author":"BG Ashford","year":"2017","unstructured":"Ashford BG, Clark J, Gupta R, Iyer NG, Yu B, Ranson M. Reviewing the genetic alterations in high-risk cutaneous squamous cell carcinoma: a search for prognostic markers and therapeutic targets. Head Neck. 2017;39(7):1462\u20139. \n                                 https:\/\/doi.org\/10.1002\/hed.24765\n                                 \n                              .","journal-title":"Head Neck"},{"issue":"9","key":"265_CR12","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1111\/j.1524-4725.2007.33224.x","volume":"33","author":"A Fuchs","year":"2007","unstructured":"Fuchs A, Marmur E. The kinetics of skin cancer: progression of actinic keratosis to squamous cell carcinoma. Dermatol Surg. 2007;33(9):1099\u2013101. \n                                 https:\/\/doi.org\/10.1111\/j.1524-4725.2007.33224.x\n                                 \n                              .","journal-title":"Dermatol Surg"},{"issue":"9","key":"265_CR13","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1111\/j.1365-4632.2010.04474.x","volume":"49","author":"DL Narayanan","year":"2010","unstructured":"Narayanan DL, Saladi RN, Fox JL. Ultraviolet radiation and skin cancer. Int J Dermatol. 2010;49(9):978\u201386.","journal-title":"Int J Dermatol"},{"issue":"3","key":"265_CR14","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.taap.2003.08.019","volume":"195","author":"Y Matsumura","year":"2004","unstructured":"Matsumura Y, Ananthaswamy HN. Toxic effects of ultraviolet radiation on the skin. Toxicol Appl Pharmacol. 2004;195(3):298\u2013308. \n                                 https:\/\/doi.org\/10.1016\/j.taap.2003.08.019\n                                 \n                              .","journal-title":"Toxicol Appl Pharmacol"},{"key":"265_CR15","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/978-3-319-56017-5_17","volume":"996","author":"S Roy","year":"2017","unstructured":"Roy S. Impact of UV radiation on genome stability and human health. Adv Exp Med Biol. 2017;996:207\u201319. \n                                 https:\/\/doi.org\/10.1007\/978-3-319-56017-5_17\n                                 \n                              .","journal-title":"Adv Exp Med Biol"},{"issue":"8","key":"265_CR16","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1111\/ddg.13614","volume":"16","author":"L Schmitz","year":"2018","unstructured":"Schmitz L, Oster-Schmidt C, Stockfleth E. Nonmelanoma skin cancer\u2014from actinic keratosis to cutaneous squamous cell carcinoma. J Dtsch Dermatol Ges. 2018;16(8):1002\u201313. \n                                 https:\/\/doi.org\/10.1111\/ddg.13614\n                                 \n                              .","journal-title":"J Dtsch Dermatol Ges"},{"issue":"5 Pt 1","key":"265_CR17","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/0190-9622(91)70113-G","volume":"24","author":"EA Olsen","year":"1991","unstructured":"Olsen EA, Abernethy ML, Kulp-Shorten C, Callen JP, Glazer SD, Huntley A, et al. A double-blind, vehicle-controlled study evaluating masoprocol cream in the treatment of actinic keratoses on the head and neck. J Am Acad Dermatol. 1991;24(5 Pt 1):738\u201343.","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 3","key":"265_CR18","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1365-2133.2007.07860.x","volume":"156","author":"J Rowert-Huber","year":"2007","unstructured":"Rowert-Huber J, Patel MJ, Forschner T, Ulrich C, Eberle J, Kerl H, et al. Actinic keratosis is an early in situ squamous cell carcinoma: a proposal for reclassification. Br J Dermatol. 2007;156(Suppl 3):8\u201312. \n                                 https:\/\/doi.org\/10.1111\/j.1365-2133.2007.07860.x\n                                 \n                              .","journal-title":"Br J Dermatol"},{"issue":"5","key":"265_CR19","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1111\/jdv.12848","volume":"29","author":"MT Fernandez-Figueras","year":"2015","unstructured":"\u2022\u2022 Fernandez-Figueras MT, Carrato C, Saenz X, Puig L, Musulen E, Ferrandiz C, et al. Actinic keratosis with atypical basal cells (AK I) is the most common lesion associated with invasive squamous cell carcinoma of the skin. J Eur Acad Dermatol Venereol. 2015;29(5):991\u20137. \n                                 https:\/\/doi.org\/10.1111\/jdv.12848\n                                 \n                              \n                              Indicates that AKs do not necessarily progress in a stepwise manner as previously thought.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"265_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14656566.2018.1523896","volume":"19","author":"E Campione","year":"2018","unstructured":"Campione E, Ventura A, Diluvio L, Mazzeo M, Mazzilli S, Garofalo V, et al. Current developments in pharmacotherapy for actinic keratosis. Expert Opin Pharmacother. 2018;19:1\u201312. \n                                 https:\/\/doi.org\/10.1080\/14656566.2018.1523896\n                                 \n                              .","journal-title":"Expert Opin Pharmacother"},{"issue":"8","key":"265_CR21","first-page":"1727","volume":"63","author":"BJ Braakhuis","year":"2003","unstructured":"Braakhuis BJ, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH. A genetic explanation of Slaughter\u2019s concept of field cancerization: evidence and clinical implications. Cancer Res. 2003;63(8):1727\u201330.","journal-title":"Cancer Res"},{"issue":"10","key":"265_CR22","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/ng.3091","volume":"46","author":"CS Lee","year":"2014","unstructured":"Lee CS, Bhaduri A, Mah A, Johnson WL, Ungewickell A, Aros CJ, et al. Recurrent point mutations in the kinetochore gene KNSTRN in cutaneous squamous cell carcinoma. Nat Genet. 2014;46(10):1060\u20132. \n                                 https:\/\/doi.org\/10.1038\/ng.3091\n                                 \n                              .","journal-title":"Nat Genet"},{"issue":"12","key":"265_CR23","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.3390\/ijms17122059","volume":"17","author":"YK Houh","year":"2016","unstructured":"Houh YK, Kim KE, Park HJ, Cho D. Roles of erythroid differentiation regulator 1 (Erdr1) on inflammatory skin diseases. Int J Mol Sci. 2016;17(12):2059. \n                                 https:\/\/doi.org\/10.3390\/ijms17122059\n                                 \n                              .","journal-title":"Int J Mol Sci"},{"issue":"4","key":"265_CR24","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/S0006-291X(03)01099-4","volume":"306","author":"TP Dooley","year":"2003","unstructured":"Dooley TP, Reddy SP, Wilborn TW, Davis RL. Biomarkers of human cutaneous squamous cell carcinoma from tissues and cell lines identified by DNA microarrays and qRT-PCR. Biochem Biophys Res Commun. 2003;306(4):1026\u201336.","journal-title":"Biochem Biophys Res Commun"},{"key":"265_CR25","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/1471-2407-13-58","volume":"13","author":"L Hameetman","year":"2013","unstructured":"Hameetman L, Commandeur S, Bavinck JN, Wisgerhof HC, de Gruijl FR, Willemze R, et al. Molecular profiling of cutaneous squamous cell carcinomas and actinic keratoses from organ transplant recipients. BMC Cancer. 2013;13:58. \n                                 https:\/\/doi.org\/10.1186\/1471-2407-13-58\n                                 \n                              .","journal-title":"BMC Cancer"},{"issue":"11","key":"265_CR26","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1001\/jamadermatol.2015.1702","volume":"151","author":"DE Levine","year":"2015","unstructured":"Levine DE, Karia PS, Schmults CD. Outcomes of patients with multiple cutaneous squamous cell carcinomas: a 10-year single-institution cohort study. JAMA Dermatol. 2015;151(11):1220\u20135. \n                                 https:\/\/doi.org\/10.1001\/jamadermatol.2015.1702\n                                 \n                              .","journal-title":"JAMA Dermatol"},{"issue":"5","key":"265_CR27","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1111\/jdv.14512","volume":"32","author":"L Schmitz","year":"2018","unstructured":"Schmitz L, Gambichler T, Gupta G, Stucker M, Stockfleth E, Szeimies RM, et al. Actinic keratoses show variable histological basal growth patterns\u2014a proposed classification adjustment. J Eur Acad Dermatol Venereol. 2018;32(5):745\u201351. \n                                 https:\/\/doi.org\/10.1111\/jdv.14512\n                                 \n                              .","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"265_CR28","doi-asserted-by":"publisher","first-page":"997","DOI":"10.2340\/00015555-2692","volume":"97","author":"R Cerio","year":"2017","unstructured":"Cerio R, Dirschka T, Dreno B, Figueras Nart I, Lear JT, Pellacani G, et al. Actinic keratosis, a chronic, progressive disease: understanding clinical gaps to optimise patient management. Acta Derm Venereol. 2017;97(8):997\u20138. \n                                 https:\/\/doi.org\/10.2340\/00015555-2692\n                                 \n                              .","journal-title":"Acta Derm Venereol"},{"issue":"8","key":"265_CR29","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1111\/jdv.14267","volume":"31","author":"T Dirschka","year":"2017","unstructured":"Dirschka T, Pellacani G, Micali G, Malvehy J, Stratigos AJ, Casari A, et al. A proposed scoring system for assessing the severity of actinic keratosis on the head: actinic keratosis area and severity index. J Eur Acad Dermatol Venereol. 2017;31(8):1295\u2013302. \n                                 https:\/\/doi.org\/10.1111\/jdv.14267\n                                 \n                              .","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"9","key":"265_CR30","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.2340\/00015555-2710","volume":"97","author":"B Dreno","year":"2017","unstructured":"Dreno B, Cerio R, Dirschka T, Nart IF, Lear JT, Peris K, et al. A novel actinic keratosis field assessment scale for grading actinic keratosis disease severity. Acta Derm Venereol. 2017;97(9):1108\u201313. \n                                 https:\/\/doi.org\/10.2340\/00015555-2710\n                                 \n                              .","journal-title":"Acta Derm Venereol"},{"issue":"10","key":"265_CR31","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1111\/ddg.13658","volume":"16","author":"L Schmitz","year":"2018","unstructured":"Schmitz L, Stucker M, Gambichler T, Stockfleth E, Dirschka T. Histological intralesional heterogeneity of actinic keratoses relates to field cancerization. J Dtsch Dermatol Ges. 2018;16(10):1211\u20137. \n                                 https:\/\/doi.org\/10.1111\/ddg.13658\n                                 \n                              .","journal-title":"J Dtsch Dermatol Ges"},{"issue":"17","key":"265_CR32","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1056\/NEJMoa1506197","volume":"373","author":"AC Chen","year":"2015","unstructured":"Chen AC, Martin AJ, Choy B, Fernandez-Penas P, Dalziell RA, McKenzie CA, et al. A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention. N Engl J Med. 2015;373(17):1618\u201326. \n                                 https:\/\/doi.org\/10.1056\/NEJMoa1506197\n                                 \n                              .","journal-title":"N Engl J Med"},{"issue":"4","key":"265_CR33","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s40257-018-0348-7","volume":"19","author":"N Jetter","year":"2018","unstructured":"Jetter N, Chandan N, Wang S, Tsoukas M. Field cancerization therapies for management of actinic keratosis: a narrative review. Am J Clin Dermatol. 2018;19(4):543\u201357. \n                                 https:\/\/doi.org\/10.1007\/s40257-018-0348-7\n                                 \n                              .","journal-title":"Am J Clin Dermatol"},{"issue":"Suppl 2","key":"265_CR34","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/jdv.14092","volume":"31","author":"E Stockfleth","year":"2017","unstructured":"Stockfleth E. The importance of treating the field in actinic keratosis. J Eur Acad Dermatol Venereol. 2017;31(Suppl 2):8\u201311. \n                                 https:\/\/doi.org\/10.1111\/jdv.14092\n                                 \n                              .","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"265_CR35","first-page":"355","volume":"101","author":"J Dong","year":"2018","unstructured":"\u2022 Dong J, Goldenberg G. Energy-based devices for actinic keratosis field therapy. Cutis. 2018;101(5):355\u201360 This article reviews laser and light therapies for field-directed treatment of AKs.","journal-title":"Cutis"},{"issue":"3","key":"265_CR36","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/dss.0000000000000308","volume":"41","author":"JR Jagdeo","year":"2015","unstructured":"Jagdeo JR, Brody NI, Spandau DF, Travers JB. Important implications and new uses of ablative lasers in dermatology: fractional carbon dioxide laser prevention of skin cancer. Dermatol Surg. 2015;41(3):387\u20139. \n                                 https:\/\/doi.org\/10.1097\/dss.0000000000000308\n                                 \n                              .","journal-title":"Dermatol Surg"},{"key":"265_CR37","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1159\/000366547","volume":"46","author":"WG Philipp-Dormston","year":"2015","unstructured":"Philipp-Dormston WG. Field cancerization: from molecular basis to selective field-directed management of actinic keratosis. Curr Probl Dermatol. 2015;46:115\u201321. \n                                 https:\/\/doi.org\/10.1159\/000366547\n                                 \n                              .","journal-title":"Curr Probl Dermatol"},{"key":"265_CR38","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2147\/CIA.S31930","volume":"8","author":"EE Uhlenhake","year":"2013","unstructured":"Uhlenhake EE. Optimal treatment of actinic keratoses. Clin Interv Aging. 2013;8:29\u201335. \n                                 https:\/\/doi.org\/10.2147\/CIA.S31930\n                                 \n                              .","journal-title":"Clin Interv Aging"},{"key":"265_CR39","unstructured":"Zyclara (imiquimod) [package insert]. 3M Health Care Limited: Loughborough; 2011."},{"key":"265_CR40","unstructured":"Aldara (imiquimod) [package insert], 3M Health Care Limited: Loughborough; 2010."},{"issue":"1","key":"265_CR41","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2340\/00015555-2167","volume":"96","author":"E Stockfleth","year":"2016","unstructured":"Stockfleth E, Sibbring GC, Alarcon I. New topical treatment options for actinic keratosis: a systematic review. Acta Derm Venereol. 2016;96(1):17\u201322. \n                                 https:\/\/doi.org\/10.2340\/00015555-2167\n                                 \n                              .","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"265_CR42","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s40800-017-0068-6","volume":"5","author":"P Kishi","year":"2018","unstructured":"Kishi P, Price CJ. Life-threatening reaction with topical 5-fluorouracil. Drug Saf Case Rep. 2018;5(1):4. \n                                 https:\/\/doi.org\/10.1007\/s40800-017-0068-6\n                                 \n                              .","journal-title":"Drug Saf Case Rep"},{"key":"265_CR43","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.pdpdt.2018.07.010","volume":"23","author":"AK Bhatta","year":"2018","unstructured":"Bhatta AK, Wang P, Keyal U, Zhao Z, Ji J, Zhu L, et al. Therapeutic effect of Imiquimod enhanced ALA-PDT on cutaneous squamous cell carcinoma. Photodiagn Photodyn Ther. 2018;23:273\u201380. \n                                 https:\/\/doi.org\/10.1016\/j.pdpdt.2018.07.010\n                                 \n                              .","journal-title":"Photodiagn Photodyn Ther"},{"issue":"8","key":"265_CR44","doi-asserted-by":"publisher","first-page":"omx043","DOI":"10.1093\/omcr\/omx043","volume":"2017","author":"K Chughtai","year":"2017","unstructured":"Chughtai K, Gupta R, Upadhaya S, Al Hadidi S. Topical 5-fluorouracil associated skin reaction. Oxf Med Case Reports. 2017;2017(8):omx043. \n                                 https:\/\/doi.org\/10.1093\/omcr\/omx043\n                                 \n                              .","journal-title":"Oxf Med Case Reports"},{"issue":"1","key":"265_CR45","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1172\/jci89820","volume":"127","author":"TJ Cunningham","year":"2017","unstructured":"Cunningham TJ, Tabacchi M, Eliane JP, Tuchayi SM, Manivasagam S, Mirzaalian H, et al. Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy. J Clin Invest. 2017;127(1):106\u201316. \n                                 https:\/\/doi.org\/10.1172\/jci89820\n                                 \n                              .","journal-title":"J Clin Invest"},{"issue":"9","key":"265_CR46","first-page":"28","volume":"11","author":"J Del Rosso","year":"2018","unstructured":"Del Rosso J, Swanson N, Berman B, Martin GM, Lin T, Rosen T. Imiquimod 2.5% and 3.75% cream for the treatment of photodamage: a meta-analysis of efficacy and tolerability in 969 randomized patients. J Clin Aesthet Dermatol. 2018;11(9):28\u201331.","journal-title":"J Clin Aesthet Dermatol"},{"issue":"1\u20132","key":"265_CR47","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.bcp.2005.10.019","volume":"71","author":"Y Ohgari","year":"2005","unstructured":"Ohgari Y, Nakayasu Y, Kitajima S, Sawamoto M, Mori H, Shimokawa O, et al. Mechanisms involved in delta-aminolevulinic acid (ALA)-induced photosensitivity of tumor cells: relation of ferrochelatase and uptake of ALA to the accumulation of protoporphyrin. Biochem Pharmacol. 2005;71(1\u20132):42\u20139. \n                                 https:\/\/doi.org\/10.1016\/j.bcp.2005.10.019\n                                 \n                              .","journal-title":"Biochem Pharmacol"},{"key":"265_CR48","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.pdpdt.2018.02.009","volume":"22","author":"EV Maytin","year":"2018","unstructured":"Maytin EV, Kaw U, Ilyas M, Mack JA, Hu B. Blue light versus red light for photodynamic therapy of basal cell carcinoma in patients with Gorlin syndrome: a bilaterally controlled comparison study. Photodiagn Photodyn Ther. 2018;22:7\u201313. \n                                 https:\/\/doi.org\/10.1016\/j.pdpdt.2018.02.009\n                                 \n                              .","journal-title":"Photodiagn Photodyn Ther"},{"issue":"6","key":"265_CR49","doi-asserted-by":"publisher","first-page":"e0157898-e","DOI":"10.1371\/journal.pone.0157898","volume":"11","author":"Y Li","year":"2016","unstructured":"Li Y, Zhang J, Xu Y, Han Y, Jiang B, Huang L, et al. The histopathological investigation of red and blue light emitting diode on treating skin wounds in Japanese big-ear white rabbit. PLoS One. 2016;11(6):e0157898-e. \n                                 https:\/\/doi.org\/10.1371\/journal.pone.0157898\n                                 \n                              .","journal-title":"PLoS One"},{"issue":"1","key":"265_CR50","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/bjd.12882","volume":"171","author":"B Petersen","year":"2014","unstructured":"Petersen B, Wiegell SR, Wulf HC. Light protection of the skin after photodynamic therapy reduces inflammation: an unblinded randomized controlled study. Br J Dermatol. 2014;171(1):175\u20138. \n                                 https:\/\/doi.org\/10.1111\/bjd.12882\n                                 \n                              .","journal-title":"Br J Dermatol"},{"key":"265_CR51","unstructured":"Gold MH, Kauvar AN, Taub AF, Geronemus RG, Ritvo EC, Goldman MP et al. The use of photodynamic therapy in dermatology: results of a consensus conference. J Drugs Dermatol. 2006;5(2)."},{"key":"265_CR52","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 Joly F, Deret S, Gamboa B, Menigot C, Fogel P, Mounier C et al. Photodynamic therapy corrects abnormal cancer-associated gene expression observed in actinic keratosis lesions and induces a remodeling effect in photodamaged skin. J Dermatol Sci. 2018. \n                                 https:\/\/doi.org\/10.1016\/j.jdermsci.2018.05.002\n                                 \n                              . Provides evidence of transcriptional remodeling of AK lesions after MAL-PDT.","DOI":"10.1016\/j.jdermsci.2018.05.002"},{"issue":"4","key":"265_CR53","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1111\/bjd.14498","volume":"175","author":"U Reinhold","year":"2016","unstructured":"Reinhold U, Dirschka T, Ostendorf R, Aschoff R, Berking C, Philipp-Dormston WG, et al. A randomized, double-blind, phase III, multicentre study to evaluate the safety and efficacy of BF-200 ALA (Ameluz((R)) ) vs. placebo in the field-directed treatment of mild-to-moderate actinic keratosis with photodynamic therapy (PDT) when using the BF-RhodoLED((R)) lamp. Br J Dermatol. 2016;175(4):696\u2013705. \n                                 https:\/\/doi.org\/10.1111\/bjd.14498\n                                 \n                              .","journal-title":"Br J Dermatol"},{"issue":"11","key":"265_CR54","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1097\/dss.0000000000000512","volume":"41","author":"A Willey","year":"2015","unstructured":"\u2022\u2022 Willey A, Anderson RR, Sakamoto FH. Temperature-modulated photodynamic therapy for the treatment of actinic keratosis on the extremities: a one-year follow-up study. Dermatol Surg. 2015;41(11):1290\u20135. \n                                 https:\/\/doi.org\/10.1097\/dss.0000000000000512\n                                 \n                              \n                              A pivotal study for thermal PDT.","journal-title":"Dermatol Surg"},{"issue":"4","key":"265_CR55","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1097\/dss.0000000000001341","volume":"44","author":"E Koo","year":"2018","unstructured":"Koo E, Austin E, Mamalis A, Jagdeo J. Thermal ultra short photodynamic therapy: heating fibroblasts during sub-30-minute incubation of 5-aminolevulinic acid increases photodynamic therapy-induced cell death. Dermatol Surg. 2018;44(4):528\u201333. \n                                 https:\/\/doi.org\/10.1097\/dss.0000000000001341\n                                 \n                              .","journal-title":"Dermatol Surg"},{"issue":"1","key":"265_CR56","doi-asserted-by":"publisher","first-page":"12599","DOI":"10.1038\/s41598-018-30908-6","volume":"8","author":"E Austin","year":"2018","unstructured":"Austin E, Koo E, Jagdeo J. Thermal photodynamic therapy increases apoptosis and reactive oxygen species generation in cutaneous and mucosal squamous cell carcinoma cells. Sci Rep. 2018;8(1):12599. \n                                 https:\/\/doi.org\/10.1038\/s41598-018-30908-6\n                                 \n                              .","journal-title":"Sci Rep"},{"issue":"6","key":"265_CR57","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/lsm.22648","volume":"49","author":"E Koo","year":"2017","unstructured":"Koo E, Austin E, Mamalis A, Jagdeo J. Efficacy of ultra short sub-30 minute incubation of 5-aminolevulinic acid photodynamic therapy in vitro. Lasers Surg Med. 2017;49(6):592\u20138. \n                                 https:\/\/doi.org\/10.1002\/lsm.22648\n                                 \n                              .","journal-title":"Lasers Surg Med"},{"issue":"3","key":"265_CR58","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/bjd.14509","volume":"175","author":"A Mamalis","year":"2016","unstructured":"\u2022\u2022 Mamalis A, Koo E, Sckisel GD, Siegel DM, Jagdeo J. Temperature-dependent impact of thermal aminolaevulinic acid photodynamic therapy on apoptosis and reactive oxygen species generation in human dermal fibroblasts. Br J Dermatol. 2016;175(3):512\u20139. \n                                 https:\/\/doi.org\/10.1111\/bjd.14509\n                                 \n                              \n                              This study provides evidence of increased apoptosis with thermal PDT.","journal-title":"Br J Dermatol"},{"issue":"3","key":"265_CR59","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1177\/1203475417752367","volume":"22","author":"SDJ Demay","year":"2018","unstructured":"Demay SDJ, Sharma K, Sapra S, Sapra R, Sapra P. Daylight-mediated photodynamic therapy with methyl aminolevulinate in actinic keratosis treatment. J Cutan Med Surg. 2018;22(3):267\u201372. \n                                 https:\/\/doi.org\/10.1177\/1203475417752367\n                                 \n                              .","journal-title":"J Cutan Med Surg"},{"issue":"1","key":"265_CR60","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1684\/ejd.2016.2882","volume":"27","author":"MC Fargnoli","year":"2017","unstructured":"Fargnoli MC, Piccioni A, Neri L, Tambone S, Pellegrini C, Peris K. Long-term efficacy and safety of daylight photodynamic therapy with methyl amninolevulinate for actinic keratosis of the face and scalp. Eur J Dermatol. 2017;27(1):89\u201391. \n                                 https:\/\/doi.org\/10.1684\/ejd.2016.2882\n                                 \n                              .","journal-title":"Eur J Dermatol"},{"issue":"12","key":"265_CR61","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1111\/jdv.13228","volume":"29","author":"JP Lacour","year":"2015","unstructured":"Lacour JP, Ulrich C, Gilaberte Y, Von Felbert V, Basset-Seguin N, Dreno B, et al. Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator-blinded, controlled, phase III study throughout Europe. J Eur Acad Dermatol Venereol. 2015;29(12):2342\u20138. \n                                 https:\/\/doi.org\/10.1111\/jdv.13228\n                                 \n                              .","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"265_CR62","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1111\/bjd.13138","volume":"171","author":"DM Rubel","year":"2014","unstructured":"Rubel DM, Spelman L, Murrell DF, See JA, Hewitt D, Foley P, et al. Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial. Br J Dermatol. 2014;171(5):1164\u201371. \n                                 https:\/\/doi.org\/10.1111\/bjd.13138\n                                 \n                              .","journal-title":"Br J Dermatol"},{"issue":"4","key":"265_CR63","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1111\/jdv.14613","volume":"32","author":"E Sotiriou","year":"2018","unstructured":"Sotiriou E, Evangelou G, Papadavid E, Apalla Z, Vrani F, Vakirlis E, et al. Conventional vs. daylight photodynamic therapy for patients with actinic keratosis on face and scalp: 12-month follow-up results of a randomized, intra-individual comparative analysis. J tEur Acad Dermatol Venereol. 2018;32(4):595\u2013600. \n                                 https:\/\/doi.org\/10.1111\/jdv.14613\n                                 \n                              .","journal-title":"J tEur Acad Dermatol Venereol"},{"issue":"4","key":"265_CR64","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1111\/j.1365-2133.2008.08450.x","volume":"158","author":"SR Wiegell","year":"2008","unstructured":"Wiegell SR, Haedersdal M, Philipsen PA, Eriksen P, Enk CD, Wulf HC. Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses; a randomized, controlled, single-blinded study. Br J Dermatol. 2008;158(4):740\u20136. \n                                 https:\/\/doi.org\/10.1111\/j.1365-2133.2008.08450.x\n                                 \n                              .","journal-title":"Br J Dermatol"},{"issue":"10","key":"265_CR65","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1111\/jdv.13076","volume":"29","author":"MC Fargnoli","year":"2015","unstructured":"Fargnoli MC, Piccioni A, Neri L, Tambone S, Pellegrini C, Peris K. Conventional vs. daylight methyl aminolevulinate photodynamic therapy for actinic keratosis of the face and scalp: an intra-patient, prospective, comparison study in Italy. J Eur Acad Dermatol Venereol. 2015;29(10):1926\u201332. \n                                 https:\/\/doi.org\/10.1111\/jdv.13076\n                                 \n                              .","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"265_CR66","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1111\/php.12923","volume":"94","author":"K Marra","year":"2018","unstructured":"Marra K, LaRochelle EP, Chapman MS, Hoopes PJ, Lukovits K, Maytin EV, et al. Comparison of blue and white lamp light with sunlight for daylight-mediated, 5-ALA photodynamic therapy, in vivo. Photochem Photobiol. 2018;94(5):1049\u201357. \n                                 https:\/\/doi.org\/10.1111\/php.12923\n                                 \n                              .","journal-title":"Photochem Photobiol"},{"issue":"3","key":"265_CR67","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1089\/pho.2017.4351","volume":"36","author":"G Paragh","year":"2018","unstructured":"Paragh G, Zeitouni NC. Two-step irradiance treatment can achieve excellent pain control during red light 5-aminolevulinic acid photodynamic therapy for actinic Keratoses. Photomed Laser Surg. 2018;36(3):174\u20136. \n                                 https:\/\/doi.org\/10.1089\/pho.2017.4351\n                                 \n                              .","journal-title":"Photomed Laser Surg"},{"issue":"7","key":"265_CR68","doi-asserted-by":"publisher","first-page":"689","DOI":"10.2340\/00015555-2931","volume":"98","author":"BJ Osiecka","year":"2018","unstructured":"Osiecka BJ, Nockowski P, Szepietowski JC. Treatment of actinic keratosis with photodynamic therapy using red or green light: a comparative study. Acta Derm Venereol. 2018;98(7):689\u201393. \n                                 https:\/\/doi.org\/10.2340\/00015555-2931\n                                 \n                              .","journal-title":"Acta Derm Venereol"},{"issue":"7","key":"265_CR69","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1001\/jamadermatol.2017.0849","volume":"153","author":"TA Petukhova","year":"2017","unstructured":"\u2022 Petukhova TA, Hassoun LA, Foolad N, Barath M, Sivamani RK. Effect of expedited microneedle-assisted photodynamic therapy for field treatment of actinic keratoses: a randomized clinical trial. JAMA Dermatol. 2017;153(7):637\u201343. \n                                 https:\/\/doi.org\/10.1001\/jamadermatol.2017.0849\n                                 \n                              \n                              This study used microneedling as a method to increase delivery of photosensitizers.","journal-title":"JAMA Dermatol"},{"issue":"1","key":"265_CR70","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/phpp.12150","volume":"31","author":"C Bay","year":"2015","unstructured":"Bay C, Lerche CM, Togsverd-Bo K, Wulf HC, Haedersdal M. Calcipotriol pretreatment enhances methyl aminolevulinate-induced protoporphyrin IX: an in vivo study in hairless mice. Photodermatol Photoimmunol Photomed. 2015;31(1):57\u201360. \n                                 https:\/\/doi.org\/10.1111\/phpp.12150\n                                 \n                              .","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"1","key":"265_CR71","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s13555-017-0219-9","volume":"8","author":"GN Galimberti","year":"2018","unstructured":"Galimberti GN. Daylight photodynamic therapy versus 5-fluorouracil for the treatment of actinic keratosis: a case series. Dermatol Ther. 2018;8(1):137\u201341. \n                                 https:\/\/doi.org\/10.1007\/s13555-017-0219-9\n                                 \n                              .","journal-title":"Dermatol Ther"},{"issue":"4","key":"265_CR72","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1111\/bjd.16473","volume":"179","author":"L Torezan","year":"2018","unstructured":"Torezan L, Grinblat B, Haedersdal M, Valente N, Festa-Neto C, Szeimies RM. A randomized split-scalp study comparing calcipotriol-assisted methyl aminolaevulinate photodynamic therapy (MAL-PDT) with conventional MAL-PDT for the treatment of actinic keratosis. Br J Dermatol. 2018;179(4):829\u201335. \n                                 https:\/\/doi.org\/10.1111\/bjd.16473\n                                 \n                              .","journal-title":"Br J Dermatol"},{"issue":"4","key":"265_CR73","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.jaad.2017.11.027","volume":"78","author":"JW Seo","year":"2018","unstructured":"Seo JW, Song KH. Topical calcipotriol before ablative fractional laser-assisted photodynamic therapy enhances treatment outcomes for actinic keratosis in Fitzpatrick grades III-V skin: a prospective randomized clinical trial. J Am Acad Dermatol. 2018;78(4):795\u20137. \n                                 https:\/\/doi.org\/10.1016\/j.jaad.2017.11.027\n                                 \n                              .","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"265_CR74","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1002\/lsm.22827","volume":"50","author":"AS Vignion-Dewalle","year":"2018","unstructured":"\u2022\u2022 Vignion-Dewalle AS, Baert G, Thecua E, Lecomte F, Vicentini C, Abi-Rached H, et al. Comparison of 10 efficient protocols for photodynamic therapy of actinic keratosis: how relevant are effective light dose and local damage in predicting the complete response rate at 3 months? Lasers Surg Med. 2018;50(5):576\u201389. \n                                 https:\/\/doi.org\/10.1002\/lsm.22827\n                                 \n                              \n                              This article compares various PDT protocols and is important for treatment optimization.","journal-title":"Lasers Surg Med"},{"issue":"4","key":"265_CR75","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1042\/BJ20150942","volume":"473","author":"H Abrahamse","year":"2016","unstructured":"Abrahamse H, Hamblin MR. New photosensitizers for photodynamic therapy. Biochem J. 2016;473(4):347\u201364.","journal-title":"Biochem J"},{"key":"265_CR76","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1758-3284-3-53","volume":"3","author":"W Jerjes","year":"2011","unstructured":"Jerjes W, Upile T, Radhi H, Hopper C. Photodynamic therapy vs photochemical internalization: the surgical margin. Head Neck Oncol. 2011;3:53. \n                                 https:\/\/doi.org\/10.1186\/1758-3284-3-53\n                                 \n                              .","journal-title":"Head Neck Oncol"},{"issue":"2","key":"265_CR77","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jdermsci.2011.04.003","volume":"63","author":"CH Wu","year":"2011","unstructured":"Wu CH, Liang CH, Shiu LY, Chang LC, Lin TS, Lan CC, et al. Solanum incanum extract (SR-T100) induces human cutaneous squamous cell carcinoma apoptosis through modulating tumor necrosis factor receptor signaling pathway. J Dermatol Sci. 2011;63(2):83\u201392. \n                                 https:\/\/doi.org\/10.1016\/j.jdermsci.2011.04.003\n                                 \n                              .","journal-title":"J Dermatol Sci"},{"issue":"3","key":"265_CR78","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.jdermsci.2018.02.015","volume":"90","author":"CC Yang","year":"2018","unstructured":"Yang CC, Wong TW, Lee CH, Hong CH, Chang CH, Lai FJ, et al. Efficacy and safety of topical SR-T100 gel in treating actinic keratosis in Taiwan: a phase III randomized double-blind vehicle-controlled parallel trial. J Dermatol Sci. 2018;90(3):295\u2013302. \n                                 https:\/\/doi.org\/10.1016\/j.jdermsci.2018.02.015\n                                 \n                              .","journal-title":"J Dermatol Sci"},{"issue":"4","key":"265_CR79","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/j.1755-148X.2011.00887.x","volume":"24","author":"E Flori","year":"2011","unstructured":"Flori E, Mastrofrancesco A, Kovacs D, Ramot Y, Briganti S, Bellei B, et al. 2,4,6-Octatrienoic acid is a novel promoter of melanogenesis and antioxidant defence in normal human melanocytes via PPAR-gamma activation. Pigment Cell Melanoma Res. 2011;24(4):618\u201330. \n                                 https:\/\/doi.org\/10.1111\/j.1755-148X.2011.00887.x\n                                 \n                              .","journal-title":"Pigment Cell Melanoma Res"},{"issue":"3","key":"265_CR80","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s13555-018-0252-3","volume":"8","author":"MP De Padova","year":"2018","unstructured":"De Padova MP, Marzani B, Pinto D, Rinaldi F. A single-arm, open-label, phase IV study to evaluate the efficacy of a topical formulation for hyperkeratotic actinic keratosis lesions. Dermatol Ther. 2018;8(3):455\u201362. \n                                 https:\/\/doi.org\/10.1007\/s13555-018-0252-3\n                                 \n                              .","journal-title":"Dermatol Ther"},{"issue":"1","key":"265_CR81","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/ddg.13373","volume":"16","author":"L Gan","year":"2018","unstructured":"Gan L, Zhang S, Poorun D, Liu D, Lu X, He M, et al. Medical applications of nonthermal atmospheric pressure plasma in dermatology. J Dtsch Dermatol Ges. 2018;16(1):7\u201313. \n                                 https:\/\/doi.org\/10.1111\/ddg.13373\n                                 \n                              .","journal-title":"J Dtsch Dermatol Ges"},{"issue":"1","key":"265_CR82","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1111\/jdv.14465","volume":"32","author":"M Wirtz","year":"2018","unstructured":"Wirtz M, Stoffels I, Dissemond J, Schadendorf D, Roesch A. Actinic keratoses treated with cold atmospheric plasma. J Eur Acad Dermatol Venereol. 2018;32(1):e37\u2013e9. \n                                 https:\/\/doi.org\/10.1111\/jdv.14465\n                                 \n                              .","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"265_CR83","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.jaad.2016.09.004","volume":"76","author":"PC Friedman","year":"2017","unstructured":"\u2022 Friedman PC, Miller V, Fridman G, Lin A, Fridman A. Successful treatment of actinic keratoses using nonthermal atmospheric pressure plasma: a case series. J Am Acad Dermatol. 2017;76(2):349\u201350. \n                                 https:\/\/doi.org\/10.1016\/j.jaad.2016.09.004\n                                 \n                              \n                              An important study for a new potential treatment modality of AKs.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"265_CR84","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jaad.2008.01.003","volume":"58","author":"MR Alexiades-Armenakas","year":"2008","unstructured":"Alexiades-Armenakas MR, Dover JS, Arndt KA. The spectrum of laser skin resurfacing: nonablative, fractional, and ablative laser resurfacing. J Am Acad Dermatol. 2008;58(5):719\u201337; quiz 38-40. \n                                 https:\/\/doi.org\/10.1016\/j.jaad.2008.01.003\n                                 \n                              .","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"265_CR85","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.jaad.2015.08.035","volume":"74","author":"SD Gan","year":"2016","unstructured":"Gan SD, Hsu SH, Chuang G, Konnikov N, Liang CA. Ablative fractional laser therapy for the treatment of actinic keratosis: a split-face study. J Am Acad Dermatol. 2016;74(2):387\u20139. \n                                 https:\/\/doi.org\/10.1016\/j.jaad.2015.08.035\n                                 \n                              .","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"265_CR86","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s00403-015-1561-3","volume":"307","author":"AM Erlendsson","year":"2015","unstructured":"Erlendsson AM, Taudorf EH, Eriksson AH, Haak CS, Zibert JR, Paasch U, et al. Ablative fractional laser alters biodistribution of ingenol mebutate in the skin. Arch Dermatol Res. 2015;307(6):515\u201322. \n                                 https:\/\/doi.org\/10.1007\/s00403-015-1561-3\n                                 \n                              .","journal-title":"Arch Dermatol Res"},{"issue":"12","key":"265_CR87","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1111\/exd.13068","volume":"25","author":"S Huth","year":"2016","unstructured":"Huth S, Marquardt Y, Amann PM, Leverkus M, Huth L, Baron JM, et al. Ablative non-sequential fractional ultrapulsed CO2 laser pretreatment improves conventional photodynamic therapy with methyl aminolevulinate in a novel human in vitro 3D actinic keratosis skin model. Exp Dermatol. 2016;25(12):997\u20139. \n                                 https:\/\/doi.org\/10.1111\/exd.13068\n                                 \n                              .","journal-title":"Exp Dermatol"},{"issue":"2","key":"265_CR88","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3109\/14764172.2013.864197","volume":"16","author":"MH Gold","year":"2014","unstructured":"Gold MH, Sensing W, Biron J. Fractional Q-switched 1,064-nm laser for the treatment of photoaged-photodamaged skin. J Cosmet Laser Ther. 2014;16(2):69\u201376. \n                                 https:\/\/doi.org\/10.3109\/14764172.2013.864197\n                                 \n                              .","journal-title":"J Cosmet Laser Ther"},{"issue":"8","key":"265_CR89","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1111\/jdv.12953","volume":"29","author":"SH Choi","year":"2015","unstructured":"Choi SH, Kim KH, Song KH. Efficacy of ablative fractional laser-assisted photodynamic therapy with short-incubation time for the treatment of facial and scalp actinic keratosis: 12-month follow-up results of a randomized, prospective, comparative trial. J Eur Acad Dermatol Venereol. 2015;29(8):1598\u2013605. \n                                 https:\/\/doi.org\/10.1111\/jdv.12953\n                                 \n                              .","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"265_CR90","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1097\/dss.0000000000001117","volume":"43","author":"M Alexiades","year":"2017","unstructured":"Alexiades M. Randomized, controlled trial of fractional carbon dioxide laser resurfacing followed by ultrashort incubation aminolevulinic acid blue light photodynamic therapy for actinic keratosis. Dermatol Surg. 2017;43(8):1053\u201364. \n                                 https:\/\/doi.org\/10.1097\/dss.0000000000001117\n                                 \n                              .","journal-title":"Dermatol Surg"},{"issue":"5","key":"265_CR91","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1111\/bjd.15272","volume":"176","author":"G Holzer","year":"2017","unstructured":"Holzer G, Pinkowicz A, Radakovic S, Schmidt JB, Tanew A. Randomized controlled trial comparing 35% trichloroacetic acid peel and 5-aminolaevulinic acid photodynamic therapy for treating multiple actinic keratosis. Br J Dermatol. 2017;176(5):1155\u201361. \n                                 https:\/\/doi.org\/10.1111\/bjd.15272\n                                 \n                              .","journal-title":"Br J Dermatol"}],"container-title":["Current Dermatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13671-019-00265-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13671-019-00265-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13671-019-00265-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T23:36:39Z","timestamp":1595028999000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13671-019-00265-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,19]]},"references-count":91,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["265"],"URL":"https:\/\/doi.org\/10.1007\/s13671-019-00265-2","relation":{},"ISSN":["2162-4933"],"issn-type":[{"value":"2162-4933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,19]]},"assertion":[{"value":"19 July 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Alisen Huang, Evan Austin, Andrew Mamalis, and Jared Jagdeo received grants from Sun Pharmaceutical Industries Ltd. Dr. Jagdeo also received personal fees from Biofrontera.Julie K. Nguyen declares no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}